Skip to Main Content

Paper Details

Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations.
J Mol Diagn
12
2022
Author NameAffiliation
Alexander DrilonMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2